# semaglutide statins

slug: semaglutide-statins · https://miscsubjects.com/a/semaglutide-statins · updated 2026-07-17T02:41:49.415Z

## Overview
Evidence is being populated by Grok web search.

## Sources

1. Effect of oral semaglutide on remnant-like lipoprotein cholesterol in patients with ischemic heart disease receiving statin therapy — https://pmc.ncbi.nlm.nih.gov/articles/PMC11954779/
2. Oral Semaglutide Further Reduced LDL Cholesterol in a Patient with Familial Hypercholesterolemia Treated with Statins, Ezetimibe, and Evolocumab — https://pubmed.ncbi.nlm.nih.gov/40866272/
3. Preparation and Therapeutic Evaluation of Engineered Semaglutide and Statin-Lipid Conjugate Nanoparticles — https://pubmed.ncbi.nlm.nih.gov/40284475/
4. Effect of oral semaglutide on remnant-like lipoprotein cholesterol levels in patients with ischemic heart disease receiving statin therapy — https://pubmed.ncbi.nlm.nih.gov/40166440/
5. Cardiovascular benefits of semaglutide: a systematic review and meta-analysis — https://pmc.ncbi.nlm.nih.gov/articles/PMC12752371/
6. Cardiovascular outcomes of semaglutide and tirzepatide for ... — https://pmc.ncbi.nlm.nih.gov/articles/PMC12823426/
7. Oral Semaglutide Further Reduced LDL Cholesterol in a Patient with Familial Hypercholesterolemia Treated with Statins, Ezetimibe, and Evolocumab — https://pmc.ncbi.nlm.nih.gov/articles/PMC13106759/
8. Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial — https://pmc.ncbi.nlm.nih.gov/articles/PMC12144549/
9. Oral Semaglutide and Change in Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial — https://pmc.ncbi.nlm.nih.gov/articles/PMC13019341/